Part,  Chapter, Paragraph

 1   II,     5. 11.Acr| Dermato-Epidemiological Network from psoriasis or psoriatic arthritis~NMSC~
 2   II,     5. 11.  2|              patients suffering from psoriasis or psoriatic arthritis~ ~
 3   II,     5. 11.  3|        suffering and incapacitation: psoriasis, atopic dermatitis, recalcitrant
 4   II,     5. 11.  3|         prevalence=9%~Mortz C, et al~Psoriasis~Summary of 18 population-based
 5   II,     5. 11.  3|            Coevorden et al, 2004).~ ~Psoriasis~Psoriasis is a common, chronic,
 6   II,     5. 11.  3|            et al, 2004).~ ~Psoriasis~Psoriasis is a common, chronic, relapsing,
 7   II,     5. 11.  3|     distinctive clinical variants of psoriasis are recognized. Plaque psoriasis
 8   II,     5. 11.  3|     psoriasis are recognized. Plaque psoriasis is most typically characterized
 9   II,     5. 11.  3|              of patients with plaque psoriasis also experience psoriatic
10   II,     5. 11.  3|         flares or relapses of plaque psoriasis may also evolve into more
11   II,     5. 11.  3|            pustular or erythrodermic psoriasis.~Psoriasis affects 15%
12   II,     5. 11.  3|             erythrodermic psoriasis.~Psoriasis affects 15% of Europeans
13   II,     5. 11.  4|              hand dermatitis or hand psoriasis confer a direct disability
14   II,     5. 11.  7|              How patients experience psoriasis: results from a European
15   II,     5. 11.  7|      Gudjonsson JE, Elder JT (2007): Psoriasis: epidemiology. Clin Dermatol
16  Key,   Ap5.  0.  0|              pseudomonas~psittacosis~psoriasis~psychiatric~psychiatrists~